主讲人：Feng Zheng

Research Assistant Professor

The Brookdale Department of Geriatrics

Division of Experimental Diabetes and Aging

Mount Sinai School of Medicine

 

时   间：07年3月23日（星期五）上午11：30

地   点：生理楼三层会议室

 

         欢迎参加。

 

 

Selected publication:

1.                     Liu H, Zheng F, Li Z, Uribarri J, Ren B, Hutter R, Tunstead JR, Badimon J, Striker GE, Vlassara H. Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol. 2006 Jul;169(1):303-13.
2.                     Vigneau C, Zheng F, Polgar K, Wilson PD, Striker G. Stem cells and kidney injury. Curr Opin Nephrol Hypertens. 2006 May;15(3):238-44. Review
3.                     Liu H, Zheng F, Cao Q, Ren B, Zhu L, Striker G, Vlassara H Amelioration of oxidant stress by the defensin lysozyme. Am J Physiol Endocrinol Metab. 2006 May;290(5):E824-32.
4.                     Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev. 2002 May-Jun;18(3):224-37. Erratum in: Diabetes Metab Res Rev. 2002 Jul-Aug;18(4):332
5.                     Zheng F, Cai W, Mitsuhashi T, Vlassara H.  Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy? Mol Med. 2001 Nov;7(11):737-47.